 | • レポートコード：MRC308GR11500 • 出版社/出版日：GlobalInfoResearch / 2023年8月14日 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の整形外科用非ステロイド性抗炎症薬（NSAID）の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の整形外科用非ステロイド性抗炎症薬（NSAID）市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 整形外科用非ステロイド性抗炎症薬（NSAID）の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
整形外科用非ステロイド性抗炎症薬（NSAID）市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・注射タイプ、経口タイプ、その他
用途別セグメント
・病院、クリニック、その他
主要な市場プレーヤー
・Merck、Bayer、JandJ、GSK、Septodont、Roche、PerioChip、Sunstar、Colgate-Palmolive、DenMat、Showa Yakuhin Kako
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、整形外科用非ステロイド性抗炎症薬（NSAID）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な整形外科用非ステロイド性抗炎症薬（NSAID）メーカーの企業概要、2019年～2022年までの整形外科用非ステロイド性抗炎症薬（NSAID）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な整形外科用非ステロイド性抗炎症薬（NSAID）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別整形外科用非ステロイド性抗炎症薬（NSAID）の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの整形外科用非ステロイド性抗炎症薬（NSAID）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での整形外科用非ステロイド性抗炎症薬（NSAID）市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および整形外科用非ステロイド性抗炎症薬（NSAID）の産業チェーンを掲載しています。
・第14、15章では、整形外科用非ステロイド性抗炎症薬（NSAID）の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 整形外科用非ステロイド性抗炎症薬（NSAID）の概要
– 種類別分析（2018年vs2022年vs2029年）：注射タイプ、経口タイプ、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、クリニック、その他
– 世界の整形外科用非ステロイド性抗炎症薬（NSAID）市場規模・予測
– 世界の整形外科用非ステロイド性抗炎症薬（NSAID）生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、Bayer、JandJ、GSK、Septodont、Roche、PerioChip、Sunstar、Colgate-Palmolive、DenMat、Showa Yakuhin Kako
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：注射タイプ、経口タイプ、その他
・用途別分析2018年-2029年：病院、クリニック、その他
・整形外科用非ステロイド性抗炎症薬（NSAID）の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・整形外科用非ステロイド性抗炎症薬（NSAID）のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・整形外科用非ステロイド性抗炎症薬（NSAID）のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・整形外科用非ステロイド性抗炎症薬（NSAID）の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・整形外科用非ステロイド性抗炎症薬（NSAID）の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Injection Type
1.3.3 Oral Type
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast
1.5.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (2018-2029)
1.5.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.1.4 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.2.4 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer Recent Developments/Updates
2.3 JandJ
2.3.1 JandJ Details
2.3.2 JandJ Major Business
2.3.3 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.3.4 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 JandJ Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.4.4 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Septodont
2.5.1 Septodont Details
2.5.2 Septodont Major Business
2.5.3 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.5.4 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Septodont Recent Developments/Updates
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.6.4 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Roche Recent Developments/Updates
2.7 PerioChip
2.7.1 PerioChip Details
2.7.2 PerioChip Major Business
2.7.3 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.7.4 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 PerioChip Recent Developments/Updates
2.8 Sunstar
2.8.1 Sunstar Details
2.8.2 Sunstar Major Business
2.8.3 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.8.4 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sunstar Recent Developments/Updates
2.9 Colgate-Palmolive
2.9.1 Colgate-Palmolive Details
2.9.2 Colgate-Palmolive Major Business
2.9.3 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.9.4 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Colgate-Palmolive Recent Developments/Updates
2.10 DenMat
2.10.1 DenMat Details
2.10.2 DenMat Major Business
2.10.3 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.10.4 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 DenMat Recent Developments/Updates
2.11 Showa Yakuhin Kako
2.11.1 Showa Yakuhin Kako Details
2.11.2 Showa Yakuhin Kako Major Business
2.11.3 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
2.11.4 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Showa Yakuhin Kako Recent Developments/Updates
3 Competitive Environment: Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Manufacturer
3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Manufacturer (2018-2023)
3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturer Market Share in 2022
3.4.2 Top 6 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturer Market Share in 2022
3.5 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Overall Company Footprint Analysis
3.5.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Region Footprint
3.5.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Company Product Type Footprint
3.5.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
4.1.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2018-2029)
4.1.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2018-2029)
4.1.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Region (2018-2029)
4.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
4.3 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
4.4 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
4.5 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
4.6 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
5.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type (2018-2029)
5.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
6.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application (2018-2029)
6.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Application (2018-2029)
7 North America
7.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
7.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
7.3 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.3.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
7.3.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
8.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
8.3 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
8.3.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
8.3.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
9.3.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
10.2 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
10.3 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.3.1 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
10.3.2 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
11.3.1 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
12.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
12.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
13.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Process
13.4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Distributors
14.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 6. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 11. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bayer Recent Developments/Updates
Table 13. JandJ Basic Information, Manufacturing Base and Competitors
Table 14. JandJ Major Business
Table 15. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 16. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. JandJ Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 21. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Septodont Basic Information, Manufacturing Base and Competitors
Table 24. Septodont Major Business
Table 25. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 26. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Septodont Recent Developments/Updates
Table 28. Roche Basic Information, Manufacturing Base and Competitors
Table 29. Roche Major Business
Table 30. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 31. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Roche Recent Developments/Updates
Table 33. PerioChip Basic Information, Manufacturing Base and Competitors
Table 34. PerioChip Major Business
Table 35. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 36. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. PerioChip Recent Developments/Updates
Table 38. Sunstar Basic Information, Manufacturing Base and Competitors
Table 39. Sunstar Major Business
Table 40. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 41. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sunstar Recent Developments/Updates
Table 43. Colgate-Palmolive Basic Information, Manufacturing Base and Competitors
Table 44. Colgate-Palmolive Major Business
Table 45. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 46. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Colgate-Palmolive Recent Developments/Updates
Table 48. DenMat Basic Information, Manufacturing Base and Competitors
Table 49. DenMat Major Business
Table 50. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 51. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. DenMat Recent Developments/Updates
Table 53. Showa Yakuhin Kako Basic Information, Manufacturing Base and Competitors
Table 54. Showa Yakuhin Kako Major Business
Table 55. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Services
Table 56. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Showa Yakuhin Kako Recent Developments/Updates
Table 58. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Site of Key Manufacturer
Table 63. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Company Product Type Footprint
Table 64. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Company Product Application Footprint
Table 65. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) New Market Entrants and Barriers to Market Entry
Table 66. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Raw Material
Table 126. Key Manufacturers of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Raw Materials
Table 127. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Distributors
Table 128. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Customers
List of Figures
Figure 1. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Figure 2. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Type in 2022
Figure 4. Injection Type Examples
Figure 5. Oral Type Examples
Figure 6. Others Examples
Figure 7. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Others Examples
Figure 12. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Region (2018-2029)
Figure 54. China Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Figure 75. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Figure 76. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in 2022
Figure 79. Manufacturing Process Analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Figure 80. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source